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With the exception of HIV, tuberculosis (TB) is the
leading cause of mortality among infectious dis-
eases. The urgent need to develop new antituber-
cular drugs is apparent due to the increasing number
of drug-resistant Mycobacterium tuberculosis (Mtb)
strains. Proteins involved in cholesterol import and
metabolism have recently been discovered as potent
targets against TB. FadA5, a thiolase from Mtb, is
catalyzing the last step of the b-oxidation reaction
of the cholesterol side-chain degradation under
release of critical metabolites and was shown to be
of importance during the chronic stage of TB infec-
tions. To gain structural and mechanistic insight on
FadA5, we characterized the enzyme in different
stages of the cleavage reaction and with a steroid
bound to the binding pocket. Structural comparisons
to human thiolases revealed that it should be
possible to target FadA5 specifically, and the ste-
roid-bound structure provides a solid basis for the
development of inhibitors against FadA5.
INTRODUCTION
The World Health Organization (WHO) is increasing its surveil-
lance of resistant Mycobacterium tuberculosis (Mtb) strains,
the causative agent of tuberculosis (TB). Out of the 8.6 million
reported tuberculosis cases in 2012, 5.2% were caused by
multidrug- and extensively drug-resistant strains, leading to a to-
tal of 1.3 million deaths worldwide (WHO, 2013), and the number
infected with drug-resistant strains is increasing.
The WHO estimates that one-third of the world’s population is
currently infected with latent TB and at least 5% of these people
develop an active form of the disease within their lifetime. An
important focus toward drug development is therefore the capa-
bility of the drug to target not only active, but also latent TB
(WHO, 2013) for which theMtb cholesterol metabolism pathway
constitutes a potential drug target (Ouellet et al., 2011). It has
been shown that cholesterol catabolism plays an importantStructure 23role in tubercular survival in host macrophages and in the mouse
model of infection (Chang et al., 2009; McLean et al., 2009; Nes-
bitt et al., 2010; Pandey and Sassetti, 2008; Yam et al., 2009).
A cluster of genes responsible for cholesterol catabolism and
import has been identified recently (Nesbitt et al., 2010; Van der
Geize et al., 2007). Themycobacterial cell entry transport system
4 (Mce4), a multisubunit ATP-binding-cassette-like (ABC-like)
transport system, for example, is used for cholesterol import
and is required for the chronic phase of TB infections in the
mouse model (Miner et al., 2009; Pandey and Sassetti, 2008).
The intracellular growth operon is required for growth of Mtb
in vitro using cholesterol as a carbon source, for intracellular
growth in macrophages, and for growth in the mouse model of
infection (Chang et al., 2007, 2009). In this pathway, acetyl-coen-
zyme A (Ac-CoA) and propionyl-CoA, as well as more complex
metabolites (Wipperman et al., 2014), are generated.
Dubnau et al. (2002) investigated which genes are preferen-
tially expressed during infection of human macrophages with
Mtb; fadA5 was one of the genes they found to be upregulated.
The fadA5 gene is located in the Mtb cholesterol catabolism
cluster, and was annotated as encoding a thiolase (Nesbitt
et al., 2010; Van der Geize et al., 2007). Recently, a phylogenetic
study of thiolases inMtb andMycobacterium smegmatis catego-
rized FadA5 as a member of the trifunctional enzyme-like thio-
lases, type 1 class. This class includes the Mtb trifunctional
enzyme, which harbors a predicted binding site for a bulky fatty
acid tail (Anbazhagan et al., 2014).
Based on the upregulation studies, the catalytic role of FadA5
and its influence on the virulence of the Mtb pathogen were
investigated. In a mouse model of infection, a DfadA5 mutant
Mtb strain displayed an attenuated disease phenotype with
reduced colony-forming units in comparison to the wild-type
(WT) strain during the chronic phase of infection. Thus, fadA5
is important for Mtb survival in vivo and may be a potential
drug target (Nesbitt et al., 2010). Biochemical studies with
FadA5 established that this enzyme is a thiolase, and the side-
chain degradation of cholesterol was identified as the point of
action (Nesbitt et al., 2010; Figure 1). Thiolases catalyze the
degradative cleavage of a b-ketoacyl-CoA to Ac-CoA and a
two-carbon shortened acyl-CoA (Figure 1A; Gilbert, 1981;
Gilbert et al., 1981). The reaction proceeds through nucleophilic
addition of an active site cysteine at the b-keto moiety of
the b-ketoacyl-CoA and elimination of Ac-CoA to form an, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 21
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Figure 1. Proposed Thiolase Reaction Mechanism and Role of FadA5 in the Side-Chain Degradation of Cholesterol
(A) The large blue arrows indicate the two reaction directions of the thiolase, the degradation is described from left to right and the biosynthesis from right to left.
The roman numerals stand for the enzyme states during thiolysis and the small blue arrows depict the electron transfer during the degradative thiolase reaction.
(Adapted from Modis and Wierenga, 2000.)
(B) FadA5 catalyzes the C-C cleavage step of the b-oxidation and, therefore, the cleavage of keto-thioesters into acetyl- (red) or propionyl- (blue) CoA and the
steroid product. (Adapted from Nesbitt et al., 2010.)
Structure
Characterization of the Mtb Thiolase FadA5acyl-cysteine intermediate (Figure 1A, state I/ II). Upon release
of the Ac-CoA product from the enzyme, CoA is bound (Fig-
ure 1A, state II/ III). The acyl-cysteine intermediate undergoes
a nucleophilic attack by the CoA to regenerate the free cysteine
and to form the two-carbon-shortened acyl-CoA (Figure 1A,
state III / IV). If the b-ketoacyl-CoA bears a methyl group at
the a-carbon, propionyl-CoA is formed instead of Ac-CoA (Fig-
ure 1B). Since the first product Ac-CoA has to be released prior
to binding of the second substrate CoA, catalysis can be des-
cribed as a ping-pong mechanism.
Although degradation is the thermodynamically favored direc-
tion, the carbon-carbon cleavage reaction is reversible. Thio-
lases are thus also found in biosynthetic pathways, and the
most intensive structural analysis to date has been performed
on the biosynthetic thiolase from Zoogloea ramigera (Kursula
et al., 2002; Modis and Wierenga, 1999, 2000). The conserved
active sites of thiolases include a nucleophilic cysteine, a general
acid/base cysteine, and a histidine (Haapalainen et al., 2006).
Toward further deciphering the role of FadA5 in cholesterol
metabolism, we solved the structure of FadA5 and characterized
its kinetics with a steroid-CoA substrate. We present structures
of this enzyme in the apo form as well as an active site variant
C93S in complex with its CoA ligand and with a noncovalently
bound steroid. Our structural characterization of a bound steroid22 Structure 23, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rightsand CoA reveals insights into steroid-enzyme interactions, as
well as regions of protein rigidity and flexibility that might serve
as a starting point for future inhibitor design.
RESULTS
FadA5 Cleaves 3,22-dioxo-chol-4-ene-24-oyl-CoA to
Yield 3-OPC-CoA and Ac-CoA
In a previous report, we explored the steady-state kinetics of
FadA5 with acetoacetyl-CoA (AcAc-CoA) and CoA as substrates
(Nesbitt et al., 2010). Although FadA5 cleaved AcAc-CoA to yield
Ac-CoA, the low catalytic activity (KmA = 464 ± 207 mM, kcat
app =
0.076 ± 0.002 s1, kcat
app/KmA = 1.64 ± 0.45 3 10
2 M1s1, at
50 mM CoA) strongly suggested that AcAc-CoA is not the physi-
ologically relevant substrate for this enzyme. Metabolite analysis
upon disruption of fadA5 inMtb identified the loss of androstene-
dione and androstadienedione accumulation in the mutant strain
(Nesbitt et al., 2010). The alteredmetabolic profile therefore led to
the hypothesis that FadA5 catalyzes the thiolysis of a keto CoA-
ester formed during the b-oxidation of the cholesterol side chain.
Based on these results, we synthesized the proposed steroid
substrate 3,22-dioxo-chol-4-ene-24-oyl-CoA (Figure 1B, com-
pound 2) to probe FadA5’s catalytic activity. FadA5 was assayed
in the thiolytic direction with 3,22-dioxo-chol-4-ene-24-oyl-CoAreserved
Table 1. FadA5 Steady-State Kinetics Parameters
Substrate Km (mM) kcat (s
1) kcat/Km (M
1s1)
O
SCoA
O
O
11.8 ± 1.4 0.725 ± 0.038 (6.14 ± 0.13) 3 104
O
SCoA
O a 464 ± 207 0.076 ± 0.002 (1.64 ± 0.45) 3 10
2
The steady-state kinetics of FadA5 were measured in multiple independent replicates. The errors are the SD of the fit.
aThe values were obtained as the apparent Km and kcat in the presence of 50 mM CoA (Nesbitt et al., 2010).
Structure
Characterization of the Mtb Thiolase FadA5and CoA as substrates, and the enzyme reaction products were
analyzed by MALDI-TOFmass spectrometry. Both 3-oxo-pregn-
4-ene-20-carboxyl-CoA (3-OPC-CoA) and Ac-CoA were formed
as predicted (Figure S1 available online). Negative controls
without the enzyme or substrates were performed and no cleav-
age activity was observed.
FadA5 Preferentially Cleaves Steroid CoA Substrates
Upon determination that FadA5 can utilize a steroid-CoA ke-
toester as a substrate, we undertook steady-state kinetic ana-
lyses to determine the extent of substrate specificity in the thio-
lytic direction. As reported previously with a cytoplasmic thiolase
from rat liver (Middleton, 1974), we observed substrate inhibition
by CoA. Therefore, the highest concentration of CoA used was
34 mM. The steady-state kinetics of FadA5 with 3,22-dioxo-
chol-4-ene-24-oyl-CoA and CoA followed a bi-bi (ping-pong)
mechanism, as determined by the best global fit of the initial
velocities to the steady-state bi-bi kinetic model assessed by
chi-square values (Martin, 1997). The KmA for 3,22-dioxo-chol-
4-ene-24-oyl-CoA is 11.8 ± 1.4 mM, the KmB for CoA is 3.10 ±
0.39 mM, and kcat is 0.725 ± 0.038 s
1, resulting in a kcat/KmA =
6.14 ± 0.13 3 104 M1s1 (Table 1). FadA5 is thus nearly 400-
fold more specific for 3,22-dioxo-chol-4-ene-24-oyl-CoA as a
substrate compared to AcAc-CoA, which is due to a 40-fold
reduction in KmA and a 10-fold increase in kcat with the steroid
substrate. Therefore, we now classify FadA5 as a degradative
thiolase or more precisely a 3-ketoacyl-CoA thiolase.
Overall Structure of FadA5
To provide insight into the structural prerequisites required to
accommodate a bulky steroid as a substrate, we solved the
structures of FadA5 in its apo form aswell as complexes contain-
ing the WT or C93S variant protein with CoA, Ac-CoA, or the ste-
roid 3-oxo-pregn-4-ene-20-carboxylic acid (OPC) and CoA. The
C93S variant was generated to prevent substrate turnover. The
first structure containing WT FadA5, CoA, or Ac-CoA (acetylated
WT[-Ac]-CoA complex) was solved by molecular replacement
using the structure of the putative Ac-CoA acetyltransferase
from Thermus thermophilus (Protein Data Bank [PDB] ID
1ULQ), which displayed the highest (43%) sequence identity to
FadA5, as a search model. All subsequent structures were
solved using the initial FadA5 structure as the search model.Structure 23Commonly, thiolases are described with a three subdomain
architecture (Sundaramoorthy et al., 2006). In this three sub-
domain model (Figure 2A), residues 1–125 and 246–266 of
FadA5 form subdomain I (N-terminal subdomain), residues
126–245 form subdomain II (lid subdomain), and residues
267–391 form subdomain III (C-terminal subdomain). Subdo-
mains I and III are structurally and functionally related. These
two subdomains are mainly characterized by a central b sheet
(b1, b3, b4, b5, and b8 in subdomain I and b9–b12 in subdomain
III) that is surrounded by three larger a helices (a1–a3 as well as
a8, a9, and a11). The two subdomains harbor the active site
residues of FadA5: cysteine 93 within h3 (h = 310helix) in sub-
domain I and histidine 347 (between helices a10 and a11)
and cysteine 377 (at the end of b11) in subdomain III (Figure 2A).
The positioning of C93 within helix h3 and right before a3 is
likely to lower the pKa of this important nucleophile through
its orientation with respect to the dipole moment of the helix
(Hol, 1985; Lodi and Knowles, 1993). Deprotonation of C93
increases its nucleophilicity, which is important for the initial thi-
olysis step (Figure 1A, step I; Price et al., 2003). In this step,
C93 is deprotonated by H347 to form a thiolate, which subse-
quently attacks the b-ketoester of the substrate. The subdo-
main I/III architecture provides a stable and rather inflexible
platform for the active site, whereas subdomain II sits on top
of the two other domains and occludes the active site residues
from the solvent, thus being called the lid subdomain (Sundar-
amoorthy et al., 2006). The lid subdomain comprises an ex-
tended structure consisting of three helices, a4–a6, and two
shorter b strands, b6 and b7, interrupted by larger disordered
regions. Analysis of the ligand-bound structures revealed the
importance of this subdomain for ligand binding, as at least
half of the protein-ligand interactions are located within this
domain (see below).
The functional entity of FadA5 is a dimer (Figure 2B), both in
the crystal and in solution as observed by multiangle light scat-
tering (Supplemental Experimental Procedures, Table S1, and
Figures S2A and S2B). The degradative thiolase class can form
dimers or tetramers (the latter are built by dimers of dimers),
but biosynthetic thiolases are reported to solely form tetramers
(Kursula et al., 2002; Modis and Wierenga, 1999). Interestingly,
the thiolase fold and the general dimerization motif seem to be
highly conserved, despite the fact that the sequence identity, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 23
Figure 2. Overall Structure of FadA5
(A) The subdomain structure of the FadA5 apo
monomer is shown as a cartoon, consisting of an
N-terminal subdomain (I, orange), a lid subdomain
(II, blue), and a C-terminal subdomain (III, green).
The thiolase active site residues C93, H347, and
C377, which are buried between subdomains I and
III and are occluded from the solvent by subdomain
II, are shown in stick presentation. (h = 310helix).
(B) FadA5 forms the typical thiolase dimer (green
monomer chain A, purple monomer chain B).
Structure
Characterization of the Mtb Thiolase FadA5between FadA5 and thiolases from other organisms does not
exceed 43% (Figure S3).
Structural Rigidity of FadA5
We solved FadA5 structures representing four different states
of the enzyme: the above-described apo structure of WT
FadA5, the acetylated WT(-Ac)-CoA complex structure, the
acetylated C93S-CoA complex structure, and the OPC com-
plex structure. These states represent different stages of the
thiolytic cleavage reaction (Figure 1A). In the acetylated WT
structure, FadA5 was found to be in complex with CoA and
Ac-CoA in chain A, whereas in chain B only CoA was bound
in two alternate conformations. Based on the electron density,
the active site cysteine C93 was modeled to be either in a non-
acetylated or in the acetylated (SCY) C93 form. All serine 93
residues of the acetylated C93S-CoA complex were acetylated
(OAS) and the enzyme was in complex with a partially occupied
CoA (Figure S4A). The last structure is a high-resolution
structure of the C93S variant in complex with the hydrolytically
cleaved product fragments CoA and OPC (OPC complex). The
structures described herein were refined to resolutions between
1.7 and 3.0 A˚ with R factors ranging between 14.5% and 24.7%
and Rfree factors ranging between 17.4% and 28.7%, respec-
tively (Table 2). All 391 residues of the FadA5 protein could
be built for the four structures with the exception of residues
138–143 in chain A of the apo structure (Figure 3A, arrow 1)
and residues 133–147 of chain D in the OPC complex (not
shown).
A similarity analysis performed with PDBeFold (European Mo-
lecular Biology Laboratory [EMBL]-EBI) revealed a high overall
structural similarity of the different FadA5 structures, indicated
also by low root-mean-square deviation (rmsd) values ranging
from 0.30 to 0.52 A˚. This observation was reinforced by
comparing the FadA5 rmsd values to the FadA5 apo structure
and the thiolase from T. thermophilus (PDB ID 1ULQ; Tables
S3 and S4 for cross-structure statistics). Differences among
the structures are mainly restricted to the lid subdomain and
located in the loop region between b5 and a4, an additional helix
a30 (R136 to I139), which is only present in the complex struc-
tures, and a flexible region close to hairpins b6 and b7. The
described differences are illustrated in Figure 3A, where the24 Structure 23, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rights reservedstrongest diverging FadA5 structures,
the apo and acetylated C93S-CoA com-
plex, are superimposed.
Interestingly, this rigidity among thio-
lases seems to be well conserved andwas also observed for other thiolases (Modis and Wierenga,
2000). The rigidity can even be extended to the position of
the active-site residues, which remained in the same conforma-
tion in the apo and in the ligand-bound structures (Figures 3B
and 3C).
The side chain of residue 93 adopted different orientations,
and, as described above, alternative conformations were ob-
served as well (S93, Figure 3C, arrow 4). These movements
were elucidated as significant, as they were significantly higher
than the coordinate errors (Table 2). In addition, the acetylated
and nonacetylated states of this residuewere present, evenwithin
the same monomer. C93 was partially acetylated in the WT(-Ac)-
CoA complex, which means that one and the same position was
occupied by alternative conformations of a C93 or an acetylated
C93 (SCY93) (see Figure 3C, arrows 5). In the acetylated C93S-
CoA complex, we observed the acetylated S93 (OAS93) without
alternative conformations (see Figure 3C, arrow 6).
Ligand and Water Binding at the Active Site
In general, the occupancy for Ac-CoA andCoA varied among the
structures and was the highest for the CoA in the OPC complex.
The quality of the electron density for the CoA ligand was a result
of the higher resolution of the OPC complex, but also may have
been due to the presence of the additional ligand, a cleaved
product, in this structure. Nevertheless, the overall orientation
of the Ac-CoA and CoA ligand was similar in all complex struc-
tures (Figure 3D). Although the orientation of the 30-phosphate-
ADP part of the ligand was quite conserved, the pantothenic
acid of the lower occupied ligand orientations and the (acety-
lated) cysteamine could adopt different orientations in the struc-
tures and, therefore, interact differently with the active site and
its surroundings.
A thiolase-specific water molecule was observed in the active
sites of the acetylated WT(-Ac)-CoA (Z253) and the OPC com-
plex (Z25) structures (Figures 3E and 4). This water was also
observed in other thiolase structures (Haapalainen et al., 2006;
Modis and Wierenga, 2000), and thus seems to be highly
conserved. It is part of the oxyanion hole 1 that is especially
important for biosynthetic thiolase reactions, where the oxyanion
hole stabilizes the transition state intermediates (Kursula et al.,
2002, 2005).
Table 2. Data Collection and Refinement Statistics
Parameter
Acetylated FadA5 WT-(Ac-)
CoA Complex FadA5 WT Apo
Acetylated FadA5
C93S-CoA Complex
FadA5 C93S OPC
Complex
Description SCY + Ac-CoA + CoA apo OAS + CoA thiolase in complex
with a cleaved product
(CoA + OPC)
Relevant buffers
Protein buffer 20 mM bicine, pH 8.5, 250 mM NaCl
Crystallization condition 0.1 M MES, pH 6.5, 4%
1,4-dioxan, 1.8 M (NH4)2SO4
0.1 M MES, pH 6.1, 5%
DMSO, 1.8 M (NH4)2SO4
0.1 M Bis-tris, pH 6.5, 0.2 M
NaCl, 25% PEG 3350
0.1 M MES, pH 6.7,
23% PEG 4000
Cryoprotectant solution 0.1 M MES, pH 6.5, 1.6 M
(NH4)2SO4, 10% 1,4-dioxan,
25% glycerol + 103 ACO
0.1 M MES, pH 6.1,
2.0 M (NH4)2SO4,
5% DMSO, 27% glycerol
0.1 M Bis-tris, pH 6.5,
0.3 M NaCl, 27% PEG 3350,
25% glycerol + 103 ACO
0.1 M MES, pH 6.7,
27% PEG 4000, 25% PEG
400 + 103 4-OPC-CoA
Data collection
Wavelength (A˚) 0.9184 0.9184 0.9537 0.9184
Temperature (K) 100 100 100 100
Space group P43212 P41212 P1211 P1211
Unit cell parameters
a/b/c (A˚) 124.68/124.68/124.71 128.31/128.31/114.07 127.61/105.16/147.66 76.82/100.39/107.98
a/b/g () 90/90/90 90/90/90 90/107/90 90/100/90
Resolution (A˚) 36.0–1.95 52.0–2.7 58.8–3.0 47.5–1.7
Number of subunits 2 2 8 4
Total reflections 1,051,278 (64,269) 190,844 (20,941) 144,763 (21,071) 1,080,779 (154,493)
Unique reflections 72,009 (4,358) 25,129 (3,358) 70,941 (10,279) 175,728 (25,549)
Completeness (%) 100.0 (100.0) 94.4 (99.5) 95.0 (95.0) 99.6 (99.7)
Ø Redundancy 14.6 (14.7) 7.6 (7.7) 2.0 (2.0) 6.0 (6.2)
< I/s (I) > 13.8 (2.5) 11.8 (2.2) 4.6 (1.3) 12.2 (2.7)
Rmerge
a (%) 13.3 (108.0) 14.3 (85.3) 17.1 (63.4) 7.5 (62.3)
Wilson B factor (A˚2)b 23.7 37.4 26.5 19.3
Refinement
Total number of atoms 6,504 6,172 23,784 13,496
Rwork/Rfree(%) 19.3/23.1 17.1/24.8 24.7/28.7 14.5/17.4
Rmsd
Bond angle () 1.3581 1.6953 1.4556 1.096
Bond length (A˚) 0.0114 0.0122 0.0123 0.007
Estimated coordinate
error (A˚) (Refmac/Phenix)
0.09 0.24 0.38 0.15
Average B factor (A˚2)c
(detailed list in Table S2)
29.9 42.6 43.9 31.7
Ramachandran plot (MolProbity)d
Most favored (%) 97.9 93.2 96.3 97.3
Allowed (%) 2.1 6.0 3.5 2.5
Disallowed (%) 0 0.8 0.2 0.2
PDB code 4UBV 4UBW 4UBU 4UBT
Values in parentheses refer to the highest resolution shell.
aRmerge = ShklSijIi - < I > j / ShklSiIi.
bTruncate (French and Wilson, 1978).
cB average (Winn et al., 2011).
dChen et al., 2010.
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Characterization of the Mtb Thiolase FadA5Even though most thiolase structures share significant
structural similarity, biosynthetic and degradative thiolases differ
with respect to the location of water molecules near their active
sites. FadA5 is comparable to the degradative thiolase fromStructure 23Saccharomyces cerevisiae (Mathieu et al., 1997), but differs from
the above-mentioned biosynthetic thiolase from Z. ramigera
and an investigated human thiolase (Kursula et al., 2005). For
the latter thiolases, a water channel to the bulk solvent water, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 25
Figure 3. Rigidity of the FadA5 Active Site
and Ligand Position
(A) Zoom into flexible parts of the superimposed
subdomain II in FadA5 apo (green) and the acet-
ylated C93S-CoA complex (brown). Arrow 1 in-
dicates a region of disordered residues in the apo
structure, arrow 2 shows the additional helix a3ʹ
that is formed in the acetylated FadA5 structures
and the OPC complex, and arrows 3 points to a
quite flexible region between L201 and Q206 with
high B factors in all four structures. Chain A and
chain B refer to the two chains of the super-
imposed molecules.
(B) Detailed stereo view of a superposition of the
active site residues C93/S93/SCY93/OAS93,
H347, and C377 of all obtained structures, indi-
cating that mainly residue 93 adopts different
conformations. FadA5 apo, green; acetylated
WT(-Ac)-CoA complex, pink; acetylated C93S-
CoA complex, brown; and OPC complex, blue.
(C) Superposition of residue 93 in FadA5 apo and
one of the other structures. Arrow 4 indicates
movement of S93 in comparison to C93 (left). Ar-
row 5 points to the position of SCY93 and C93 in
chain A of the acetylated WT structure (middle).
Arrow 6 indicates the position of OAS93 in the
acetylated C93S-CoA structure (right). Color
coded as described above.
(D) Superposition of the (Ac-)CoA traces of the
three complex structures shown in stereo. The
pink and rose Ac-CoA and CoA traces belong to
the acetylated WT(-Ac)-CoA complex structure,
where both ligands are binding to chain A. Arrow 7
shows the additional helix a3ʹ. Color coded as
described above.
(E) Two of the four FadA5 structures (acetylated
WT[-Ac]-CoA andOPC complex structure) contain
a central water molecule in the active site that is
also present in the biosynthetic thiolase (black)
structures at the same position. Color coded as
described above.
Structure
Characterization of the Mtb Thiolase FadA5and awater reservoir located near the active site were described,
whereas only the reservoir could be observed in the FadA5 struc-
tures, but the channel where the water chain would be located
was blocked by two hydrophobic residues, I314 and V322.
The Acetylated WT(-Ac)-CoA Complex
The acetylated WT(-Ac)-CoA complex was obtained after the
protein was incubated with a 10-fold molar excess of Ac-CoA.
Both monomers in this structure contained a partially occupied
native (C93) and an acetylated active site cysteine, C93
(SCY93). In chain A, a mixture of Ac-CoA (50%) and CoA (40%)
was present according to the electron density, whereas chain
B only contained CoA as a ligand, but also in a higher (40%)26 Structure 23, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rights reservedand a lower (30%) occupied conforma-
tion. The ligand densities were not very
well defined, and, in both chains, a third
even less occupied conformation might
be present but was not modeled. In addi-
tion to the ligand densities, we observed
diffuse difference density in the steroid-binding pocket that could not be explained as ligand or solvent
molecules and, therefore, remains uninterpreted.
In the degradative thiolase reaction, an acylated cysteine
is formed upon nucleophilic attack of the cysteine on the
b-carbonyl (Figure 1A, state I/ II). The intermediate state (Fig-
ure 1A, state II) is mimicked in our structure by an acetylation of
C93 where the larger steroid (R) is substituted by a methyl group
that does not reach into the void of the proposed steroid-binding
pocket. Even though the electron density for SCY93 as well as
for the Ac-CoA and CoA was only partially present (Figure S4B)
in the acetylated WT(-Ac)-CoA complex structure, we were able
to observe different conformations of the active site cysteine 93
compared to the apo structure. The sulfur was shifted by 25 in
Figure 4. Interaction Network of Bound Ac-CoA and CoA
(A) Stereo view of the Ac-CoA (gray) and FadA5 (acetylated WT[-Ac]-CoA structure) interaction via water- (red spheres) mediated hydrogen bonds (dashed lines)
as well as direct contacts and a p-cation-stacking interaction (orange ellipse) of the adenosine moiety of CoA with R221. The active site residues interact with
each other via direct and water-mediated contacts; a central position is assumed by water molecule Z253.
(B) CoA (gray) and FadA5 (OPC complex) interact similarly as described in (A); a central position is assumed by water molecule Z25. The residues are colored
according to the subdomain color code.
Structure
Characterization of the Mtb Thiolase FadA5the direction of the active site H347 and also the native C93 of the
complex structure was shifted to a greater extent by 95 (see Fig-
ure 3C, arrow 5).
The shift of the sulfur in both SCY93s positioned the acetyl
group directly into the open space of the steroid-binding pocket
and a substitution of the methyl group of the acetyl by the steroid
would be readily accommodated. This movement of the active
site C93 or its covalent modification, respectively, has also
been described for other thiolases (Modis and Wierenga,
2000), and the alternative conformations obtained were also
found for the Z. ramigera thiolase (Kursula et al., 2002).
In both protein chains, we observed a stronger binding for one
of the two described ligands, indicated by a higher number of
direct and indirect contacts, in comparison to the other ligand.
Ac-CoA in chain A assumed three direct contacts with residues
Q151, R221, and H347 and 12 additional water-mediated in-
teractions. Residues of subdomain II provided half of these
contacts, but the Ac-CoA was also connected to the catalytic
residues C93 and C377 by the oxyanion hole water Z253 (Fig-
ure 4A). The plane of the ligand’s nucleotide heterocycle was
positioned parallel to the guanidine function of R221 and formed
a p-cation stacking interaction at a distance of 3.7 A˚ (Figure 4A,
orange ellipse). The CoA ligand of chain A formed a total of only
five water-mediated interactions to the protein, and, in addition,
a weaker p-cation stacking interaction with R221, as the parallel
geometry seemed to be imperfect (Figure S4C).Structure 23The catalytic triad residues were also connected to each other
via a network of water-mediated and direct contacts. SCY93 did
not form any interaction with the catalytic triad or the ligand, but
C93 was in direct contact with H347. C377 was located farther
away and, therefore, only interacted via the oxyanion hole water
with C93. In chain B, the higher occupied CoA adopted 14 direct
or water-mediated contacts, including the catalytic triad,
whereas the lower occupied CoA only formed six contacts with
the protein and was not interacting with the active site.
FadA5 in Complex with a Hydrolyzed Steroid-CoA
The C93S variant of FadA5 was cocrystallized with a 10-fold
molar excess of the enzyme reaction product 3-OPC-CoA,
which led to a complex containing FadA5, free CoA, and the ste-
roid derivative OPC in our structure. The OPC complex structure
contained four protein chains (A–D) in the asymmetric unit. An
interesting aspect of the OPC complex structure was the struc-
tural diversity of these different subunits. Residues 133–147 of
subdomain II were not resolved in chain D, but could bemodeled
in the other chains. This disorder also extended to the active site.
The CoA ligand was modeled for all four chains, whereas OPC
could not be modeled for chain D.
The subsequent analysis is based on chain A in the OPC com-
plex structure. Serine 93 within the catalytic triad adopted two
different conformations pointing in opposite directions, but
neither of these conformations was identical to the C93, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 27
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Characterization of the Mtb Thiolase FadA5conformation of the apo protein (Figures 3B and 3C). One of
these conformations, S93-B, was shifted by 80 (SGC93apo;
CBC93apo; OGS93-B) compared to apo C93, whereas the sec-
ond, denoted as S93-A, differed by an angle of 79 (SGC93apo;
CBC93apo; OGS93-A).
As discussed above, neither the product nor CoA binding
induced a large conformational change within the overall struc-
ture, and thus CoA assumed similar contacts with the active
site residues as described for the Ac-CoA of chain A or CoA of
chain B in the acetylated WT(-Ac)-CoA complex structure (Fig-
ure 4A). Beyond the active site, three direct interactions of CoA
with residues Q151, T223, and S246 and one additional water-
mediated interaction with Q247 were observed. The first three
were partially present in the acetylated WT(-Ac)-CoA complex
structure, depending on the ligand orientation, but the last inter-
action could only be observed in the OPC structure (Figure 4B).
OPC (Figure 5A) is not the native product of the thiolase reac-
tion; rather it was generated during crystallization by hydrolysis
of the thioester bond of compound 3 (Figure 1B) to release free
CoA. Given that OPC is a steroid, it is not surprising that it mainly
formed hydrophobic interactions with the enzyme and was
located in a pocket that was mostly built by the lid subdomain,
engaging residues L128–I139 and N150–Q151. An interesting
contact was formed by N68 of the neighboring monomer that
also contributed its side chain to the steroid-binding pocket.
Although polar amino acids were also part of the pocket, the ste-
roid-packing interactions were provided through main chain, Cb
or Cg atoms (Figure 5A). Interestingly, the C3 ketone did not form
any interaction with surrounding residues or water molecules.
The carboxyl function of OPC formed one direct hydrogen
bond to the amino group of residue G379, and it interacted
with the B conformation of the active site S93. In addition to
these interactions, the distance between the formerly covalently
connected atoms CAQ and S1P increased to 3.9 A˚.
The position of the OPC binding pocket reveals intriguing
insights with respect to the thiolase dimer. Whereas the lid sub-
domain of chain A aswell as residues from the N-terminal subdo-
main of the other monomer occluded the hydrophobic OPC
molecule from the solvent (Figure 5B, gray surface), CoA, on
the other hand, was far more exposed to the solvent and did
not reach beneath the protein surface.
In chains B and D, an alternative conformation of the CoA
ligand could be modeled. The alternative conformation in chain
B affected the thiol and the neighboring C2P only, whereas, in
the CoA of chain D, a long stretch of the CoA chain, ranging
from the thiol back to the C9P, adopted an alternative conforma-
tion. The two thiols of CoA in chain B were twisted by 96; one
thiol was pointing toward the OPC (SH-B) and superimposed
with the thiol of chain A (Figure S5A), while the other thiol (SH-
A) pointed away from the OPC (Figure S5B). Even though both
conformations were well defined in the electron density maps,
the one pointing toward the OPC assumed the higher occu-
pancy. In this chain, in contrast to chain A, OPC and CoA
assumed hardly any direct contact, the distance was 3.4 A˚, but
the angle was not optimal for a hydrogen bond interaction; the
most intriguing aspect was the positive difference density (Fig-
ure S5B, green) located around S93-B and between this residue
and the OPC molecule. This difference density was also partially
present in chain A, but the size and shape was most prominent28 Structure 23, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rightsfor chain B and its ligands. We hypothesize that this density is
a relic from the uncleaved 3-OPC-CoA that was originally used
for crystallization; however, modeling of 3-OPC-CoA into this dif-
ference density was not possible due to its very low occupancy.
As already mentioned, chains A to C contained the OPCmole-
cule, but it was not possible to model OPC in chain D, although
some partial density was observed in the binding pocket. In addi-
tion, the comparably high B factors of the CoA ligand bound to
chain D indicated a higher flexibility or disorder. The flexibility
of the CoA ligand may be directly linked to the absence of the
OPC, as described above. This strengthens our hypothesis
that only upon occupation of the steroid-binding pocket the
(Ac-)CoA ligand is tightly bound or correctly positioned. We
therefore propose that chain D represents an open enzyme state
after catalysis when the product is released.
The Steroid-Binding Pocket
Although the steroid-binding pocket was present in all described
FadA5 structures (the exceptions being FadA5 apo chain A and
OPC complex chain D), the question arises whether the rigidity
of the overall structure extends to this area as well. A super-
position of selected chains of the four structures shows that res-
idues R136 and Q151 assumed different conformations due to
ligand binding (Figures 5C and 5D). The guanidine function of
R136 in the OPC complex structure (blue, bound OPC) was
shifted by 84–90 compared to the other complex structures.
Binding of the hydrophobic OPC thus led to an extended confor-
mation of this arginine residue (Figure 5C, arrow 1). The apo
structure (green) differed with respect to both polypeptides in
the dimer. R136 in chain A of the apo structure (Figure 5C, arrow
2) was located approximately 6 A˚ farther away from the OPC
binding site than in the OPC structure, which is most likely linked
to the disorder after amino acid 137. Glutamine 151 assumed a
bent conformation in the OPC complex structure (see Figure 5D,
arrow 3), but an extended conformation in the other structures.
The bend angle, £ðCDOPC; CBOPC; CDothersÞ, of Q151 was be-
tween 90 and 110 (Figure 5D, yellow dots) in the different chains
and was required to accommodate the OPC, which would not fit
into the pocket if the glutamine remained in its extended confor-
mation. In chain D of the same structure, however, where noOPC
could be modeled, this residue adopted two alternative confor-
mations, one in the bent and one in an extended conformation.
DISCUSSION
We pursued the structural and functional characterization of
themycobacterial FadA5 protein to provide insight into its mech-
anism and to utilize this knowledge for inhibitor design. Our
different structures represent three of the five states in the thio-
lase reaction cycle (Figure 1A) and, thus, permit detailed mech-
anistic insights. For the first step of the cleavage reaction, the
b-keto thioester substrate (Figure 1B compound 2) forms a
complex with the apo enzyme. We solved the structure of the
apo enzyme and showed that it is structurally highly similar to
the complex structures with bound ligands. We can therefore hy-
pothesize that, in state I (Figure 1A), the only visible movement
upon binding of the substrate would be a shift of C93 to permit
entry to the steroid-binding pocket, as was observed in all of
our complex structures.reserved
Figure 5. Binding and Steroid-Binding Pocket
of the Hydrolyzed Steroid
(A) SIGMAA-weighted 2Fo-Fc electron density omit
map (s = 1.0; gray) of OPC (yellow; chemical structure
on the left). OPC is shownwith respect to the active site
residues and residues of the lid subdomain (blue) that
are forming a hydrophobic pocket to bind OPC; the
protein (OPC complex structure, chain A) is depicted in
cartoon representation in the according subdomain
color code.
(B) Surface presentation of the enzyme dimer (OPC
complex structure, chain B, gray) illustrating the posi-
tioning of CoA and OPC (both yellow) with respect to
chain A (blue), where the more flexible lid subdomain is
highlighted by the deep blue coloring. OPC is buried in
a hydrophobic pocket built mainly by residues of sub-
domain II but also a small part of chain B. Main parts of
CoA are solvent exposed.
(C and D)Movements of residues R136 (arrows 1 and 2)
and Q151 (arrow 3) caused by OPC binding in the OPC
complex structure (blue) in comparison to the other
structures are shown in stereo. The atoms used for the
angle determination are labeled and indicated by yel-
low dots (residue color code: acetylated WT[-Ac]-CoA
complex, pink; apo, green; and acetylated C93S-CoA
complex, brown).
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Characterization of the Mtb Thiolase FadA5State II of this cycle is represented by the acetylated WT
(-Ac)-CoA complex structure, where the active site cysteine
C93 of the acylated enzyme is in close proximity to an Ac-
CoA molecule that, theoretically, was just cleaved off the sub-
strate. In our structure, the acylation with a bulky steroid is
mimicked by the much shorter acetyl, but even in the presence
of this shortened compound the orientation of the real substrate
is unambiguous and is confirmed by the OPC complex
structure. The OPC complex structure mimicks state III (Fig-
ure 1A) and deciphers the occupation of the steroid-binding
pocket with the required residue movements, i.e., Q151 and
R136, for proper binding. These movements (Figures 5C and
5D) hold the shortened steroid in place until it is transferred to
CoA. The mimic is not perfect, as we did not observe a cova-
lent bond between the active site residue S93 and OPC. In the
case of a covalent complex, one would expect a single confor-
mation of S93 in the B orientation of the two observed conforma-
tions and an OPC molecule that is in slightly closer proximity to
the CoA than observed in our structure. In addition to OPC, the
complex contains a bound CoA molecule that can be acti-
vated by deprotonation with the help of a C377 thiolate. The acti-
vated CoA reacts with the covalently bound product that is
thereby released from the enzyme. Finally, the enzyme is in
complex with a more loose, noncovalently bound intermediate
(Figure 1A, state IV), for which we do not have structural informa-
tion so far.
The general question that arises and cannot completely be
solved here is the binding and release mechanism of the
steroid. They are located in a hydrophobic binding pocket during
catalysis, but, due to the rigidity of the enzyme in the apo or
ligand-bound state, it is not clear whether the compound is trans-
ferred along the CoA-binding site and the catalytic triad or if a
larger reorientation of the steroid-binding loop occurrs. The fact
that a hydrophobic compound would have to pass along hydro-
philic binding regionsmakes reorientation or opening of the bind-
ing loop more plausible. This hypothesis is also supported by
chain D of the OPC complex structure where the OPC is absent
from the binding pocket and a highly disordered binding loop
(residues G133–D147) and a more flexible bound CoA ligand
are present. In this chain, we thus observe a snapshot with an
opened binding loop that may just have released its product
and displays a solvent-exposed steroid-binding site. The lower
occupied CoA (Figure S4B) or Ac-CoA ligands observed in the
other structures together with the more flexible bound CoA in
chain D of the OPC complex suggest that high occupancy CoA
binding in FadA5 only occurrs when the steroid-binding pocket
is occupied. However, we do not observe a structural difference
in the CoA-binding pocket of the steroid-bound and steroid-free
structures and thus cannot explain this phenomenon. Based on
our different enzyme snapshots, we hypothesize, despite the
fact that the overall fold of the protein was rigid, that FadA5
undergoes larger reorientations to allow substrate entry and
product release and that an occupation of both binding sites is
essential for tight ligand binding and for catalysis.
As cholesterol metabolism became the focus of being an
anti-TB drug target, the question of FadA5’s potential and the
feasibility of drug development arises. Despite their sequence
differences, thiolases display a highly conserved fold throughout
the entire enzyme class, which leads to the question of whether30 Structure 23, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rightsFadA5 can be specifically targeted without inhibiting human thi-
olases as well.
Humans contain six different thiolases and three of them, the
cytosolic thiolase (CT), the mitochondrial T2-thiolase (T2), and
the peroxisomal AB-thiolase (AB), have been structurally charac-
terized; for the remaining three thiolases (mitochondrial T1-thio-
lase [T1], peroxisomal SCP2-thiolase [SCP2], and mitochondrial
trifunctional enzyme thiolase [TFE]) models were generated.
As shown in Figure 6A, the CT, the T2, and the T1-thiolases
structurally diverge the most from FadA5. These thiolases form
a tetramerization loop instead of a steroid-binding pocket. Res-
idues emerging from this loop cut directly through the position of
the OPC. Human AB and SCP2 are structurally more closely
related to FadA5, and we cannot exclude the possibility that
they would be targeted by FadA5 inhibitors. However, super-
position of AB and FadA5 revealed that some residues within
the steroid-binding loop of the AB are disordered and others re-
placed by shorter ones, so that the observed shielding of the ste-
roid may not be possible (Figure 6B). Concerning the SCP2, only
25% of the generated models adopted a similar steroid-binding
pocket as observed in FadA5 (not shown).
Lastly, the TFE seems to be the closest relative to FadA5 and
is probably the most critical to be targeted by FadA5 drug can-
didates. However, a structure prediction using the I-TASSER
server (Roy et al., 2010; Zhang, 2008) suggested that the TFEs
are structurally more related to the T2 and CT enzymes, by form-
ing a tetramerization loop instead of a steroid-binding pocket,
and thus targeted FadA5 inhibition may be feasible (Figure 6C).
To provide initial insights about how FadA5 inhibitors should
look, a hotspot analysis (Supplemental Experimental Proce-
dures) of the steroid- and CoA-binding pocket, using HotspotsX
(Neudert and Klebe, 2011), was performed. The analysis indi-
cated that inhibitory potency might be gained, for example, by
involving the carbonyl oxygen of the catalytic residue H347 in a
hydrogen or halogen bond (Figure S6).
FadA5’s preference for a steroid b-keto-CoA thioester sub-
strate in combination with previous metabolic profiling data
(Nesbitt et al., 2010) strongly supports that its in vivo catalytic ac-
tivity is the catalysis of thiolytic degradation of the cholesterol
side chain. Our structural analysis of four FadA5 structures
thus provides important insights into steroid complex formation
and ligand binding for a degradative thiolase. In particular, the
OPC complex structure permitted the observation of how a large
hydrophobic compound is accommodated in the substrate-
binding pocket and oriented with respect to the active site.
Based on our structural data, combined with our hotspot anal-
ysis and the preliminary structural homology analysis demon-
strating the low similarity of FadA5 compared to the human
thiolases, we are optimistic that specific targeting of FadA5 is
feasible. As a starting point, steroid-like compounds could
be used for inhibitor design with specific and targeted function-
alization of the ring-system extending toward the CoA-binding
pocket.EXPERIMENTAL PROCEDURES
FadA5 Expression and Purification
See the Supplemental Experimental Procedures for the protein expression and
purification.reserved
Figure 6. Superposition of FadA5 with Different Human Thiolases
Superposition of the FadA5 OPC complex monomer (blue) with structures or
models of different human thiolases. OPC is depicted in surface representation
(yellow, red). Regions in the human thiolases that are located in close proximity
to the bound OPC are also shown in transparent surface representation. The
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FadA5 was assayed for thiolytic activity with 3,22-dioxo-chol-4-ene-24-oyl-
CoA and CoA as substrates at 30C. The thiolytic activity was followed at
303 nmusing a UV/vis spectrophotometer with a Peltier temperature controller
(Shimadzu Scientific Instruments) by monitoring the disappearance of the
Mg2+-3,22-dioxo-chol-4-ene-24-oyl-CoA complex (Middleton, 1974; Nesbitt
et al., 2010). The assay was carried out with 28 nM FadA5 in 100 mM Tris-
HCl, pH 8.1, containing 25 mM MgCl2, 1.25–60 mM 3,22-dioxo-chol-4-ene-
24-oyl-CoA, and 1.07–34 mM CoA. The initial velocity was determined from
the linear portion of the reaction progress curve, and the initial burst of activity
before reaching steady state was disregarded. Steady-state kinetic parame-
ters were obtained from global hyperbolic fits of the initial velocity data using
Grafit4. The substituted enzyme (bi-bi, ping-pong) mechanistic Equation 1
provided the best fit to the data, where A = 3,22-dioxo-chol-4-ene-24-oyl-
CoA; B = CoA; KB = Km for CoA; KA = Km for 3,22-dioxo-chol-4-ene-24-oyl-
CoA; and Vmax = maximal velocity.
v =
Vmax½A½B
KB½A+KA½B+ ½A½B (Equation 1)
See the Supplemental Experimental Procedures for the substrate synthesis.
Crystallization and Data Collection
The detailed crystallization and cryoprotectant conditions are listed in Table 2.
FadA5 WT apo (12 mg/ml) was mixed in a one-to-one ratio with the crystalliza-
tion buffer and set up for crystallization at 20C. For cocrystallization with Ac-
CoA (dissolved in water), the protein (FadA5 WT and FadA5 C93S) samples
(12 mg/ml) were incubated with a 10-fold molar excess of Ac-CoA (ACO) for
30 min at 4C prior to crystallization. The samples were mixed in a one-to-
one ratio with the crystallization buffer (Table 2) and were set up for crystalliza-
tion at 20C. For cocrystallization trials, 3-OPC-CoA (Figure 1, compound 3)
was dissolved in the protein buffer and added to the FadA5 C93S variant
(12 mg/ml) in a 10-fold molar excess; the mixture was immediately used for
crystallization in a one-to-one ratio with its crystallization solution (Table 2).
Prior to flash-freezing, the crystals were briefly transferred into a cryoprotec-
tant solution (Table 2).
All FadA5WT data sets were collected at Berliner Speicherring-Gesellschaft
fu¨r Synchrotronstrahlung (BESSY II), beamline MX 14.1, with a MAR mosaic
225 detector. The CoA containing C93S variant data set was collected with
a MAR mosaic 225 detector at the European Synchrotron radiation facility
(ESRF), beamline BM 14U. The C93S containing 3-OPC-CoA data set was
collected at BESSY II, beamline MX 14.1, with a PILATUS 6M detector.
Structure Determination
All data sets were integrated with iMosflm (Leslie, 1992) and scaled with Scala
(Evans, 2006) or Aimless (Evans, 2011). For phasing of the first data set (acet-
ylated WT[-Ac]-CoA) molecular replacement was performed with Phaser
(McCoy et al., 2007) using the putative Ac-CoA acetyltransferase from Ther-
mus thermophiles (PDB ID 1ulq) with 43% sequence identity to FadA5 as a
search model. Automatic model building was conducted with the help of
ARP/wARP (Langer et al., 2008) and Buccaneer (Cowtan, 2006). Manual model
building subsequently was performed with Coot (Emsley and Cowtan, 2004),
and the structure was further refined with REFMAC (Murshudov et al., 1997;
Winn et al., 2011).
For all subsequent data sets, molecular replacement was performed using
chain A of the acetylatedWT(-Ac)-CoA structure (excluding ligands and solvent
molecules) as the search model using Phaser. Model building for the FadA5
WT apo structure was performed as described above. For refinement and
model building of the acetylated C93S-CoA complex, thin-shell andsteroid-binding loop (arrow 1) and the tetramerization loop (arrow 2) are
shown.
(A) Superposition with structures of CT (1WL4, violet) and T2 (2IB7, pink) as
well as a model of the T1 (green).
(B) Superposition with the structure of the AB-thiolase (2IIK, green).
(C) Superposition with the model of TFE (cyan). The CoA molecule is shown in
all-sticks presentation.
, 21–33, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 31
Structure
Characterization of the Mtb Thiolase FadA5noncrystallographic symmetry refinement, including the CoA ligand, was used.
Refinement cycles for the OPC complex were conducted with Phenix (Adams
et al., 2010). The PRODRG server (Schu¨ttelkopf and van Aalten, 2004) was
used to create library files for geometry restraints as well as structure files of
Ac-CoA (ACO is the abbreviation in the coordinate file), SCY, OAS, OPC, and
CoA. MolProbity (Chen et al., 2010) analysis was performed to validate the
structures. Figures of all structures were generated using PyMOL (DeLano,
2002) after secondary structure assignment by DSSP (Joosten et al., 2011;
Kabsch and Sander, 1983); sequence alignments and comparisons were per-
formed with CLUSTAL W (Thompson et al., 1994) and ESPript (Gouet et al.,
2003).
ACCESSION NUMBERS
The coordinates and structure factors of FadA5 in its apo form as well as the
different complexes have been deposited in the PDBwith the accession codes
4UBT, 4UBU, 4UBV, and 4UBW, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at http://
dx.doi.org/10.1016/j.str.2014.10.010.
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